S

Singular Genomics Systems Inc
NASDAQ:OMIC

Watchlist Manager
Singular Genomics Systems Inc
NASDAQ:OMIC
Watchlist
Price: 20.01 USD Market Closed
Market Cap: 50.6m USD

Operating Margin
Singular Genomics Systems Inc

-3 488.5%
Current
-3 178%
Average
3.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 488.5%
=
Operating Profit
-93m
/
Revenue
2.7m

Operating Margin Across Competitors

No Stocks Found

Singular Genomics Systems Inc
Glance View

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. The company is headquartered in La Jolla, California and currently employs 221 full-time employees. The company went IPO on 2021-05-27. The firm has developed an NGS technology or sequencing engine. The company is developing two integrated solutions that are built to target specific applications. The firm's first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which is collectively referred as G4 Integrated Solution. The G4 Instrument is a sequencer designed to produce accurate genetic sequencing results. Its second integrated solution in development comprises an instrument and an associated menu of consumable kits, which is collectively referred as PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a multiomics solution.

OMIC Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 488.5%
=
Operating Profit
-93m
/
Revenue
2.7m
What is the Operating Margin of Singular Genomics Systems Inc?

Based on Singular Genomics Systems Inc's most recent financial statements, the company has Operating Margin of -3 488.5%.

Back to Top